Prospective Registry of Acute Heart Failure

Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Observational
SUMMARY

Objectives: * To create an observational registry of all patients hospitalized for a AHF * To determine the precise prevalence of etiologies and the prognostic factors of AHF in a non selected population. Among the prognostic factors, to establish the specific role of acute renal failure * To establish the optimal initial assessment of patients hospitalized for heart failure * To validate and compare with prospective data the results of a retrospective cohort study carried out at the University Hospital of Geneva who established the re-hospitalization and mortality outcome of patients hospitalized for heart failure. Method: Creation of an observational registry associated with a biobank including patients hospitalized for AHF in the Department of General Internal medicine (SMIG) and in the Departments of Specialties at the University Hospital of Geneva. Anticipated results: * To identify the prevalence of the etiologies and the prognostic factors of the heart failure * To establish the optimal initial assessment of the patients hospitalized for a heart failure. Among the prognostic factors, to establish the specific role of acute renal failure * To validate and compare results of a retrospective cohort study carried out at the University Hospital of Geneva which established the re-hospitalization and mortality outcome of patients hospitalized AHF * To improve the management of hospitalized patients with AHF with a robust identification of the etiologies and a better identification of high-risk patients.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 16
Maximum Age: 100
Healthy Volunteers: f
View:

• Usual clinical presentation of acute heart failure as defined by the European Society of Cardiology : Gradual onset or new or worsening symptoms of rapid heart failure (eg, dyspnea, edema of the lower limbs and tiredness ) and signs of heart failure (eg elevation of jugular venous pressure, crackles, moving the shock peak) requiring urgent treatment.

• Brain natriuretic peptide or value of brain natriuretic peptide (BNP) greater than 100 ng / L.

Locations
Other Locations
Switzerland
Geneva University Hospitals
RECRUITING
Geneva
Contact Information
Primary
Sebastian Carballo, MD
sebastian.carballo@hcuge.ch
+41223729216
Time Frame
Start Date: 2014-12
Estimated Completion Date: 2026-11
Participants
Target number of participants: 1200
Sponsors
Leads: Sebastian Carballo

This content was sourced from clinicaltrials.gov